Advertisement
Screener

Zoetis Inc. (ZTS) Capital Expenditures

2.8 / 5 stars · 68/120 Roast Me

Zoetis Inc. Capital Expenditures

Zoetis Inc. (ZTS) reported Capital Expenditures of $227.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Cash Flow › Investing Activities

us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-06

  • Zoetis Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $117.00M, a 19.86% decline year-over-year.
  • Zoetis Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $110.00M, a 38.20% decline year-over-year.
  • Zoetis Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $161.00M, a 25.46% decline year-over-year.
  • Zoetis Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $136.00M, a 18.56% decline year-over-year.
  • Zoetis Inc. payments to acquire property, plant, and equipment for fiscal 2025 was $621.00M, a 5.19% decline from fiscal 2024.
  • Zoetis Inc. payments to acquire property, plant, and equipment for fiscal 2024 was $655.00M, a 10.52% decline from fiscal 2023.
  • Zoetis Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $732.00M, a 24.91% increase from fiscal 2022.
  • Zoetis Inc. payments to acquire property, plant, and equipment for fiscal 2022 was $586.00M, a 22.85% increase from fiscal 2021.
Period endPayments to Acquire Property, Plant, and Equipment 3 monthPayments to Acquire Property, Plant, and Equipment 3 month as first filedPayments to Acquire Property, Plant, and Equipment 6 monthPayments to Acquire Property, Plant, and Equipment 6 month as first filedPayments to Acquire Property, Plant, and Equipment 9 monthPayments to Acquire Property, Plant, and Equipment 12 month
2026-06-30$117.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
$227.00M
10-Q · filed 2026-08-06
$388.00M
derived: sum of 3 quarters · filed 2026-08-06
$524.00M
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31$110.00M
10-Q · filed 2026-05-07
$271.00M
derived: sum of 2 quarters · filed 2026-05-07
$407.00M
derived: sum of 3 quarters · filed 2026-05-07
$553.00M
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31$161.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12
$297.00M
derived: sum of 2 quarters · filed 2026-02-12
$443.00M
derived: sum of 3 quarters · filed 2026-08-06
$621.00M
10-K · filed 2026-02-12
2025-09-30$136.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04
$282.00M
derived: sum of 2 quarters · filed 2026-08-06
$460.00M
10-Q · filed 2025-11-04
$676.00M
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30$146.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
$324.00M
10-Q · filed 2026-08-06
$327.00M
10-Q · filed 2025-08-05
$540.00M
derived: sum of 3 quarters · filed 2026-08-06
$707.00M
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31$178.00M
10-Q · filed 2026-05-07
$149.00M
10-Q · filed 2025-05-06
$394.00M
derived: sum of 2 quarters · filed 2026-05-07
$561.00M
derived: sum of 3 quarters · filed 2026-05-07
$693.00M
derived: sum of 4 quarters · filed 2026-05-07
2024-12-31$216.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12
$383.00M
derived: sum of 2 quarters · filed 2026-02-12
$515.00M
derived: sum of 3 quarters · filed 2026-02-12
$655.00M
10-K · filed 2026-02-12
2024-09-30$167.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04
$299.00M
derived: sum of 2 quarters · filed 2025-11-04
$439.00M
10-Q · filed 2025-11-04
$637.00M
derived: sum of 4 quarters · filed 2026-02-12
2024-06-30$132.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05
$272.00M
10-Q · filed 2025-08-05
$470.00M
derived: sum of 3 quarters · filed 2026-02-12
$615.00M
derived: sum of 4 quarters · filed 2026-02-12
2024-03-31$140.00M
10-Q · filed 2025-05-06
$338.00M
derived: sum of 2 quarters · filed 2026-02-12
$483.00M
derived: sum of 3 quarters · filed 2026-02-12
$649.00M
derived: sum of 4 quarters · filed 2026-02-12
2023-12-31$198.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12
$343.00M
derived: sum of 2 quarters · filed 2026-02-12
$509.00M
derived: sum of 3 quarters · filed 2026-02-12
$732.00M
10-K · filed 2026-02-12
2023-09-30$145.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04
$311.00M
derived: sum of 2 quarters · filed 2024-11-04
$534.00M
10-Q · filed 2024-11-04
$705.00M
derived: sum of 4 quarters · filed 2025-02-13
2023-06-30$166.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06
$389.00M
10-Q · filed 2024-08-06
$560.00M
derived: sum of 3 quarters · filed 2025-02-13
$714.00M
derived: sum of 4 quarters · filed 2025-02-13
2023-03-31$223.00M
10-Q · filed 2024-05-02
$394.00M
derived: sum of 2 quarters · filed 2025-02-13
$548.00M
derived: sum of 3 quarters · filed 2025-02-13
$694.00M
derived: sum of 4 quarters · filed 2025-02-13
2022-12-31$171.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13
$325.00M
derived: sum of 2 quarters · filed 2025-02-13
$471.00M
derived: sum of 3 quarters · filed 2025-02-13
$586.00M
10-K · filed 2025-02-13
2022-09-30$154.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02
$300.00M
derived: sum of 2 quarters · filed 2023-11-02
$415.00M
10-Q · filed 2023-11-02
$583.00M
derived: sum of 4 quarters · filed 2024-02-13
2022-06-30$146.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08
$261.00M
10-Q · filed 2023-08-08
$429.00M
derived: sum of 3 quarters · filed 2024-02-13
$548.00M
derived: sum of 4 quarters · filed 2024-02-13
2022-03-31$115.00M
10-Q · filed 2023-05-04
$283.00M
derived: sum of 2 quarters · filed 2024-02-13
$402.00M
derived: sum of 3 quarters · filed 2024-02-13
$515.00M
derived: sum of 4 quarters · filed 2024-02-13
2021-12-31$168.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13
$287.00M
derived: sum of 2 quarters · filed 2024-02-13
$400.00M
derived: sum of 3 quarters · filed 2024-02-13
$477.00M
10-K · filed 2024-02-13
2021-09-30$119.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03
$232.00M
derived: sum of 2 quarters · filed 2022-11-03
$309.00M
10-Q · filed 2022-11-03
$461.00M
derived: sum of 4 quarters · filed 2023-02-14
2021-06-30$113.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04
$190.00M
10-Q · filed 2022-08-04
$342.00M
derived: sum of 3 quarters · filed 2023-02-14
$459.00M
derived: sum of 4 quarters · filed 2023-02-14
2021-03-31$77.00M
10-Q · filed 2022-05-05
$229.00M
derived: sum of 2 quarters · filed 2023-02-14
$346.00M
derived: sum of 3 quarters · filed 2023-02-14
$436.00M
derived: sum of 4 quarters · filed 2023-02-14
2020-12-31$152.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14
$269.00M
derived: sum of 2 quarters · filed 2023-02-14
$359.00M
derived: sum of 3 quarters · filed 2023-02-14
$453.00M
10-K · filed 2023-02-14
2020-09-30$117.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04
$207.00M
derived: sum of 2 quarters · filed 2021-11-04
$301.00M
10-Q · filed 2021-11-04
$467.00M
derived: sum of 4 quarters · filed 2022-02-15
2020-06-30$90.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05
$184.00M
10-Q · filed 2021-08-05
$350.00M
derived: sum of 3 quarters · filed 2022-02-15
$478.00M
derived: sum of 4 quarters · filed 2022-02-15
2020-03-31$94.00M
10-Q · filed 2021-05-06
$260.00M
derived: sum of 2 quarters · filed 2022-02-15
$388.00M
derived: sum of 3 quarters · filed 2022-02-15
$491.00M
derived: sum of 4 quarters · filed 2022-02-15
2019-12-31$166.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15
$294.00M
derived: sum of 2 quarters · filed 2022-02-15
$397.00M
derived: sum of 3 quarters · filed 2022-02-15
$460.00M
10-K · filed 2022-02-15
2019-09-30$128.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05
$231.00M
derived: sum of 2 quarters · filed 2020-11-05
$294.00M
10-Q · filed 2020-11-05
$432.00M
derived: sum of 4 quarters · filed 2021-02-16
2019-06-30$103.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06
$166.00M
10-Q · filed 2020-08-06
$304.00M
derived: sum of 3 quarters · filed 2021-02-16
$378.00M
derived: sum of 4 quarters · filed 2021-02-16
2019-03-31$63.00M
10-Q · filed 2020-05-06
$201.00M
derived: sum of 2 quarters · filed 2021-02-16
$275.00M
derived: sum of 3 quarters · filed 2021-02-16
$348.00M
derived: sum of 4 quarters · filed 2021-02-16
2018-12-31$138.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16
$212.00M
derived: sum of 2 quarters · filed 2021-02-16
$285.00M
derived: sum of 3 quarters · filed 2021-02-16
$338.00M
10-K · filed 2021-02-16
2018-09-30$74.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07
$147.00M
derived: sum of 2 quarters · filed 2019-11-07
$200.00M
10-Q · filed 2019-11-07
$283.00M
derived: sum of 4 quarters · filed 2020-02-13
2018-06-30$73.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06
$126.00M
10-Q · filed 2019-08-06
$209.00M
derived: sum of 3 quarters · filed 2020-02-13
$257.00M
derived: sum of 4 quarters · filed 2020-02-13
2018-03-31$53.00M
10-Q · filed 2019-05-02
$136.00M
derived: sum of 2 quarters · filed 2020-02-13
$184.00M
derived: sum of 3 quarters · filed 2020-02-13
$235.00M
derived: sum of 4 quarters · filed 2020-02-13
2017-12-31$83.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13
$131.00M
derived: sum of 2 quarters · filed 2020-02-13
$182.00M
derived: sum of 3 quarters · filed 2020-02-13
$224.00M
10-K · filed 2020-02-13
2017-10-01$48.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01
$99.00M
derived: sum of 2 quarters · filed 2018-11-01
$141.00M
10-Q · filed 2018-11-01
$201.00M
derived: sum of 4 quarters · filed 2019-02-14
2017-07-02$51.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02
$93.00M
10-Q · filed 2018-08-02
$153.00M
derived: sum of 3 quarters · filed 2019-02-14
$210.00M
derived: sum of 4 quarters · filed 2019-02-14
2017-04-02$42.00M
10-Q · filed 2018-05-02
$102.00M
derived: sum of 2 quarters · filed 2019-02-14
$159.00M
derived: sum of 3 quarters · filed 2019-02-14
$213.00M
derived: sum of 4 quarters · filed 2019-02-14
2016-12-31$60.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-14
$117.00M
derived: sum of 2 quarters · filed 2019-02-14
$171.00M
derived: sum of 3 quarters · filed 2019-02-14
$216.00M
10-K · filed 2019-02-14
2016-10-02$57.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02
$111.00M
derived: sum of 2 quarters · filed 2017-11-02
$156.00M
10-Q · filed 2017-11-02
$237.00M
derived: sum of 4 quarters · filed 2018-02-15
2016-07-03$54.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08
$99.00M
10-Q · filed 2017-08-08
$180.00M
derived: sum of 3 quarters · filed 2018-02-15
$232.00M
derived: sum of 4 quarters · filed 2018-02-15
2016-04-03$45.00M
10-Q · filed 2017-05-04
$126.00M
derived: sum of 2 quarters · filed 2018-02-15
$178.00M
derived: sum of 3 quarters · filed 2018-02-15
$224.00M
derived: sum of 4 quarters · filed 2018-02-15
2015-12-31$81.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-15
$133.00M
derived: sum of 2 quarters · filed 2018-02-15
$179.00M
derived: sum of 3 quarters · filed 2018-02-15
$224.00M
10-K · filed 2018-02-15
2015-09-27$52.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03
$98.00M
derived: sum of 2 quarters · filed 2016-11-03
$143.00M
10-Q · filed 2016-11-03
$194.00M
derived: sum of 4 quarters · filed 2017-02-16
2015-06-28$46.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05
$91.00M
10-Q · filed 2016-08-05
$142.00M
derived: sum of 3 quarters · filed 2017-02-16
$184.00M
derived: sum of 4 quarters · filed 2017-02-16
2015-03-29$45.00M
10-Q · filed 2016-05-06
$96.00M
derived: sum of 2 quarters · filed 2017-02-16
$138.00M
derived: sum of 3 quarters · filed 2017-02-16
$180.00M
derived: sum of 4 quarters · filed 2017-02-16
2014-12-31$51.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-16
$93.00M
derived: sum of 2 quarters · filed 2017-02-16
$135.00M
derived: sum of 3 quarters · filed 2017-02-16
$180.00M
10-K · filed 2017-02-16
2014-09-28$42.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05
$84.00M
derived: sum of 2 quarters · filed 2015-11-05
$129.00M
10-Q · filed 2015-11-05
$178.00M
derived: sum of 4 quarters · filed 2016-02-24
2014-06-29$42.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06
$87.00M
10-Q · filed 2015-08-06
$136.00M
derived: sum of 3 quarters · filed 2016-02-24
$191.00M
derived: sum of 4 quarters · filed 2016-02-24
2014-03-30$45.00M
10-Q · filed 2015-05-07
$94.00M
derived: sum of 2 quarters · filed 2016-02-24
$149.00M
derived: sum of 3 quarters · filed 2016-02-24
$207.00M
derived: sum of 4 quarters · filed 2016-02-24
2013-12-31$49.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24
$104.00M
derived: sum of 2 quarters · filed 2016-02-24
$162.00M
derived: sum of 3 quarters · filed 2016-02-24
$184.00M
10-K · filed 2016-02-24
2013-09-29$55.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10
$113.00M
derived: sum of 2 quarters · filed 2014-11-10
$135.00M
10-Q · filed 2014-11-10
$180.00M
derived: sum of 4 quarters · filed 2015-02-27
2013-06-30$58.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12
$80.00M
10-Q · filed 2014-08-12
$125.00M
derived: sum of 3 quarters · filed 2015-02-27
$151.00M
derived: sum of 4 quarters · filed 2015-02-27
2013-03-31$22.00M
10-Q · filed 2014-05-13
$67.00M
derived: sum of 2 quarters · filed 2015-02-27
$93.00M
derived: sum of 3 quarters · filed 2015-02-27
$117.00M
derived: sum of 4 quarters · filed 2015-02-27
2012-12-31$45.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27
$71.00M
derived: sum of 2 quarters · filed 2015-02-27
$95.00M
derived: sum of 3 quarters · filed 2015-02-27
$126.00M
10-K · filed 2015-02-27
2012-09-30$26.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13
$50.00M
derived: sum of 2 quarters · filed 2013-11-13
$81.00M
10-Q · filed 2013-11-13
2012-07-01$24.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14
$55.00M
10-Q · filed 2013-08-14
2012-04-01$31.00M
10-Q · filed 2013-05-15
2011-12-31$135.00M
10-K · filed 2014-03-26

Similar stocks

Stock NameCountryMarket CapPE Ratio
INSMED Inc (INSM)United States$26.566B-26.60
Roivant Sciences Ltd. (ROIV)$26.105B-96.08
ALNYLAM PHARMACEUTICALS, INC. (ALNY)United States$33.420B54.94
Royalty Pharma plc (RPRX)United States$22.628B
UNITED THERAPEUTICS Corp (UTHR)United States$20.249B17.64
Viatris Inc (VTRS)United States$20.008B-0.00
Jazz Pharmaceuticals plc (JAZZ)$15.333B16.07
Summit Therapeutics Inc. (SMMT)United States$13.071B-13.21
BridgeBio Pharma, Inc. (BBIO)United States$12.947B-20.72
CORCEPT THERAPEUTICS INC (CORT)United States$12.804B169.10